In Quintara Biosciences v. Ruifeng Biztech, the Ninth Circuit held that a district court improperly dismissed trade secrets based on California’s disclosure rules, emphasizing that DTSA claims follow the Federal Rules of Civil Procedure and that trade secret specificity is typically a fact issue for later stages of litigation.
